Company
Headquarters: Singapore, Singapore
Employees: 137
CEO: Mr. Tian Sang Ng
S$29.1 Million
SGD as of Jan. 1, 2024
US$22.1 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Beverly JCG Ltd., an investment holding company, engages in the trading and distribution, and medical businesses in Singapore, Malaysia, the People's Republic of China, and Taiwan. The company operates through Trading and Distribution; Aesthetic Medical and Healthcare; and Investment and Others segments. The Trading and Distribution segment engages in the trading and distribution of steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron and steel foundries, and aluminum smelters in the Asia-Pacific region, as well as provision of ancillary services. The Aesthetic Medical segment provides aesthetic medical services, including the provision of aesthetic dental care and cosmetic surgery, beauty, and wellness services in Asia. The Investment and Others segment provides management services, as well as marketing, distribution, and related services. Beverly JCG Ltd. also offers day care, physiotherapy, spa, reflexology, and chiropractic and traditional treatment services. The company was formerly known as JCG Investment Holdings Ltd. and changed its name to Beverly JCG Ltd. in July 2020. Beverly JCG Ltd. was founded in 1987 and is based in Singapore.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Beverly JCG Ltd has the following listings and related stock indices.
Stock: SGX: VFP wb_incandescent